Browsing: GLP-1s
McDonald’s is exploring an $8.5 billion bet on a fast food wave led by protein-maxxing and GLP-1s
The health wave has made its impact on what could have been considered its mortal enemy: fast food. In a…
Weight loss drugs are changing the economic picture from many angles. In addition to reshaping the healthcare, retail, and leisure…
The luxury sector is weathering crosswinds at the moment: On the one hand, military conflict in the Middle East has…
The most consequential thing to happen to the American food system in the past two years arrived as a weekly…
Yuling Luo rang the Nasdaq closing bell Friday having taken his first company public in a massively oversubscribed round. The…
Ozempic mania has even Olive Garden and The Cheesecake Factory cutting back on portion sizes
Special menus with petite, less expensive portions are popping up all over, from large chains like Olive Garden and The…
Meat snacks have emerged as the clear winner of America’s seismic GLP-1 consumption shift
The meat stick, long associated with truck stops and road trips, has undergone a rebranding. Fueled by a national obsession…
GLP-1s could end up being ‘the first true longevity drug’ as the world battles a rising obesity crisis
GLP-1s are the hottest drugs on the market. While doctors have prescribed these drugs to treat type-2 diabetes for decades,…
In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator,…
Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro
Gallup released a survey this week showing that the obesity rate among US adults has fallen to 37% this year, a significant…











